Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Novo Nordisk (NYSE:NVO) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 8 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 0 | 2 | 0 | 0 | 0 |
3M Ago | 0 | 4 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $160.38, a high estimate of $163.00, and a low estimate of $160.00. This current average represents a 0.77% decrease from the previous average price target of $161.62.
![1725901239_0_0.png](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240910/43393900-0-5fbc01a5c0737991f2e6619ba70b7c43.png/big)
Investigating Analyst Ratings: An Elaborate Study
The perception of Novo Nordisk by...
Login or create a forever free account to read this news
Sign up/Log in